more controversy over the long-term safety and benefits of testosterone replacement in middle-aged and older men

October 2013

You'll hear more controversy over the long-term safety and benefits of testosterone replacement in middle-aged and older men.

Drug companies spend over $100 million/yr promoting these products.

But there's not much evidence of significant improvements with testosterone replacement...and even less evidence of long-term safety.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

12 issues every year, with brief articles about new meds and hot topics
200+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

Vaccines three new versions of the flu vaccine this season
Allergic Reactions More patients who are allergic to penicillin will get a cephalosporin for common respiratory tract infections
Dermatology Recent warnings about acetaminophen will bring up more questions about serious drug-induced skin reactions
Antibiotics stronger warnings about peripheral neuropathy with oral or IV quinolone antibiotics
Cardiology Many patients don't get appropriate med DOSES after a heart attack
Liver Disease myths about using meds in chronic liver disease
Malaria Stronger warnings about mefloquine will mean more questions about what meds to use to prevent malaria
Interactions P-glycoprotein drug interactions
Veterinary Medicine More pharmacies are providing human and veterinary meds for pets
Osteoporosis how to manage osteoporosis when patients don't get enough benefit from a bisphosphonate
Men's Health more controversy over the long-term safety and benefits of testosterone replacement in middle-aged and older men